| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5708745 | The Journal of Arthroplasty | 2017 | 26 Pages |
Abstract
IA TXA is noninferior to IV TXA in terms of fall in Hb on the first postoperative day. Due to the potential for reduced serum levels and easier administration (single dose), this trial supports the use of IA TXA for primary TKA.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Navendu MBBS, MS (Ortho), DNB (Ortho), Darren B. MBBS, FRACS (Ortho), Ian A. MBBS, FRACS (Ortho), Neville J. MBBS, FRACS (Ortho), George MBBS, FRACS (Ortho), Samuel J. MBBS, FRACS (Ortho),